Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia.

Sukkarieh HH, Al Fayez N, Al-Omar HA, Azmi NO, Syed B, Albar RA, Al Bali N

DOI: 10.3389/fphar.2025.1712147
Published: 2025
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2025.1712147,
  title = {Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia.},
  author = {Sukkarieh HH and Al Fayez N and Al-Omar HA and Azmi NO and Syed B and Albar RA and Al Bali N},
  year = {2025},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2025.1712147},
  url = {https://doi.org/10.3389/fphar.2025.1712147}
}

RIS

TY  - JOUR
TI  - Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia.
AU  - Sukkarieh HH
AU  - Al Fayez N
AU  - Al-Omar HA
AU  - Azmi NO
AU  - Syed B
AU  - Albar RA
AU  - Al Bali N
PY  - 2025
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2025.1712147
UR  - https://doi.org/10.3389/fphar.2025.1712147
ER  -

APA

HH, S., N, A. F., HA, A., NO, A., B, S., RA, A., & N, A. B. (2025). Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2025.1712147

Source records

pubmed · retrieved 2026-09-27T01:43:05.060Z